- Prevention in FocusA complex range of interrelated and synergistic factors contribute to a higher risk of HIV infection for some individuals in certain populations disproportionately affected by the HIV epidemic in…
- Prevention in FocusAlthough there may be significant benefits to disclosing one’s HIV status to others, there may also be significant drawbacks. We review the evidence related to HIV disclosure to sexual partners,…
- Prevention in FocusIgnited by National HIV Testing Day in the United States, which occurs annually on June 27th, the AIDS Committee of Windsor holds an annual HIV Testing Day in their region. The 2015 campaign saw a…
- The following report previously appeared in CATIE News. We are putting it in this issue of TreatmentUpdate to underscore some of the issues related to care and ...
- Researchers in Australia conducted a study to understand the reasons why some HIV-positive people have either not started potent combination anti-HIV therapy ...
- Post-exposure prophylaxis, or PEP, is a way to help prevent the transmission of HIV in an HIV-negative person who may have been recently exposed to the virus. It involves taking HIV medications as…
- Oral pre-exposure prophylaxis, or PrEP, is a way for an HIV-negative person who is at risk of HIV infection to reduce their risk of getting HIV by taking antiretroviral drugs.
- CATIE NewsDue to shared routes of infection, co-infection with HIV and hepatitis C virus (HCV) is relatively common. Chronic infection with HCV injures the liver and ...
- Finding out you have HIV may be a shock. But you do not have to go through this alone: There is help.
- Abacavir hypersensitivity screening can help to identify people who are at high risk for a serious adverse reaction to the anti-HIV drug abacavir (Ziagen, ABC) or any drug containing abacavir.
- CATIE NewsResearchers have found that some conditions and diseases impact men and women differently, such as the following: . cancer. cardiovascular disease. autoimmune ...